ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,731,532 | -11.4% | 63,800 | +0.3% | 0.02% | -7.4% |
| Q2 2023 | $1,955,064 | -18.2% | 63,600 | -4.1% | 0.03% | -22.9% |
| Q1 2023 | $2,388,789 | -8.8% | 66,300 | 0.0% | 0.04% | -16.7% |
| Q4 2022 | $2,620,176 | -0.7% | 66,300 | +0.9% | 0.04% | -4.5% |
| Q3 2022 | $2,639,000 | -4.1% | 65,700 | +0.3% | 0.04% | 0.0% |
| Q2 2022 | $2,753,000 | +21.9% | 65,500 | +12.9% | 0.04% | +46.7% |
| Q1 2022 | $2,259,000 | -3.9% | 58,000 | -1.7% | 0.03% | +3.4% |
| Q4 2021 | $2,351,000 | +10.6% | 59,000 | +0.3% | 0.03% | 0.0% |
| Q3 2021 | $2,125,000 | -15.8% | 58,800 | -4.5% | 0.03% | -12.1% |
| Q2 2021 | $2,525,000 | -5.7% | 61,600 | +0.3% | 0.03% | -10.8% |
| Q1 2021 | $2,678,000 | +153.6% | 61,400 | +191.0% | 0.04% | +146.7% |
| Q4 2020 | $1,056,000 | – | 21,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |